The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Vera Therapeutics shares saw a notable increase ahead of an anticipated decision from the U.S. FDA. Meanwhile, Steel Partners made a proposal to acquire InMode for $16.75 per share. Additionally, Greenwich LifeSciences shares rose following approval from the European Medicines Agency regarding its experimental drug GP2.